METHOD AND APPARATUS FOR ADDING BUFFERS AND OTHER SUBSTANCES TO MEDICAL CARTRIDGES
Anesthetics and other medical solutions are stored in a cartridge including a hollow body having a needle-penetrable septum at one end and a plunger at another end. A protective plug is inserted into the open plunger end of the cartridge and protects the cartridge from contamination per use. A buffer or other material may be injected into the cartridge, causing displacement of the protective plug, allowing the cartridge to then be used in a syringe or other delivery system. The anesthetic may contain at least one solute and have an initial tonicity and an initial pH. A volume of buffer may be injected through the septum into the anesthetic, where the initial solute concentration and initial pH of the anesthetic may be selected to provide a target pH and target tonicity after the buffer is introduced.
1 . A liquid medicament cartridge comprising:
a hollow body having a first open end and a second open end;
a needle-penetrable septum over the first open end;
a plunger spaced inwardly from the second open end; and
a protective plug inserted into the second open end, said protective plug being displaceable as additional liquid is injected through the septum into the hollow body to cause the plunger to move toward the plug.
2 . A medicament cartridge as in claim 1 , wherein the hollow body comprises a glass tube.
3 . A medicament cartridge as in claim 1 , wherein the protective plug has a distal end which engages the plunger and a proximal end which covers the second opening to maintain sterility.
4 . A medicament cartridge as in claim 3 , wherein the proximal end of the plug is configured so that it cannot be pushed into the second open end of the hollow body to prevent premature inward displacement of the plunger.
5 . A medicament cartridge as in claim 3 , wherein the proximal end of the plug is configured so that it is difficult to manually grasp when present over the second open end of the hollow body and easier to grasp when displaced proximally from the second open end.
6 . A medicament cartridge as in claim 1 , further comprising a liquid medicament present in an interior of the hollow body.
7 . A medicament cartridge as in claim 6 , wherein the liquid medicament comprises an anesthetic solution.
8 . A method for buffering a medicament solution carried in a container, said method comprising:
injecting a buffer into the container to outwardly displace a plunger which in turn ejects a protective plug which covers an open end of the container.
9 . A method as in claim 8 , wherein the protective plug prevents contamination of the cartridge prior to ejection.
10 . A method as in claim 8 , wherein the protective plug prevents inward displacement of the plunger prior to ejection.
11 . A method as in claim 8 , wherein the plunger is configured so that it cannot be pushed into the container.
12 . A method as in claim 8 , wherein the liquid medicament comprises an anesthetic solution.
13 . A method for buffering a liquid medicament having a target tonicity and pH, said method comprising:
providing a volume of the liquid anesthetic in a sealed container having a septum at one end and a plunger at an opposite end, wherein the medicament contains at least one solute and has an initial tonicity and an initial pH; and
injecting a volume of buffer through the septum into the medicament;
wherein the liquid medicament has an initial solute concentration and an initial pH selected so that the buffered medicament will have both the target pH and the target tonicity.
14 . A method as in claim 13 , wherein the target tonicity is less than 500 mOsm/kg.
15 . A method as in claim 13 , wherein the target tonicity is less than 400 mOsm/kg.
16 . A method as in claim 13 , wherein the target tonicity is substantially isotonic.
17 . A method as in claim 13 , wherein the liquid medicament comprises an anesthetic solution.
18 . A method as in claim 13 , wherein the anesthetic originally has a pH below 6.0 and the volume of buffer raises the pH of the buffered anesthetic to a target pH of at least 7.0.
19 . A method as in claim 18 , wherein the volume of buffer increases the pH to a target pH of at least 7.3.
20 . A method as in claim 19 , wherein the target pH is at least 7.45.
21 . A method as in claim 13 , wherein the at least one solute comprises sodium choride.
22 . A method as in claim 13 , wherein the anesthetic further comprises a vasoconstrictor.
23 . A method as in claim 22 , wherein the vasoconstrictor comprises levonordefrine.
24 . A method as in claim 22 , wherein the vasoconstrictor comprises epinephrine.
25 . A method as in claim 13 , wherein the buffer comprises sodium bicarbonate solution.
26 . A method as in claim 13 , wherein the cartridge is prepared at a central manufacturing facility and the cartridges are distributed to a plurality of local users, wherein the users add the buffer to the cartridges.
27 . A method as in claim 26 , wherein the users inject the buffer prior to a procedure, in order to produce buffered medicament for use in the procedure.
28 . A method as in claim 27 , wherein at least a portion of the buffered medicament is injected into a patient within two minutes of introducing the buffer.
29 . A method as in claim 13 , wherein the local anesthetic is an amide local anesthetic.
30 . A method as in claim 13 , wherein the local anesthetic is an amine local anesthetic.
31 . A method as in claim 13 , wherein the local anesthetic is lidocaine.
32 . A method as in claim 13 , wherein the local anesthetic is articaine.
33 . A method as in claim 13 , wherein the local anesthetic is mepivacaine.
34 . A method as in claim 13 , wherein an internal volume of the anesthetic cartridge is in the range from 1.45 ml to 2.3 ml, the anesthetic volume is in the range from 1.15 ml to 2.2 ml, and the buffer volume is in the range from 0.05 ml to 0.5 ml.